Sinopharm
1099.HK
#2702
Rank
โ‚น615.16 B
Marketcap
โ‚น197.13
Share price
-2.73%
Change (1 day)
-2.28%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.753 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.753 Trillion. In 2025 the company made a revenue of โ‚น7.753 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.553 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.753 T2.65%
2024โ‚น7.553 T-5.1%
2023โ‚น7.959 T5.42%
2022โ‚น7.550 T-2.1%
2021โ‚น7.711 T16.85%
2020โ‚น6.599 T14.95%
2019โ‚น5.741 T21.52%
2018โ‚น4.724 T5.93%
2017โ‚น4.460 T27.22%
2016โ‚น3.505 T5.37%
2015โ‚น3.326 T9.14%
2014โ‚น3.048 T17.22%
2013โ‚น2.600 T25.94%
2012โ‚น2.064 T34.61%
2011โ‚น1.533 T55.34%
2010โ‚น987.45 B35.79%
2009โ‚น727.19 B37.56%
2008โ‚น528.65 B31.43%
2007โ‚น402.24 B40.26%
2006โ‚น286.77 B